112235 ⎘
Vectors comprising a targeting moiety Vectors comprising a peptide as targeting moiety, e.g. a synthetic peptide, from undefined source
Sub-classes:MEMBRANE-PENETRATING PEPTIDES TO ENHANCED TRANSFECTION AND COMPOSITIONS AND METHODS FOR USING SAME
#2DIRECT REPLACEMENT GENOME EDITING
#3MEMBRANE-PENETRATING PEPTIDES TO ENHANCED TRANSFECTION AND COMPOSITIONS AND METHODS FOR USING SAME
#4COMPOSITIONS AND METHODS FOR IMPROVING THE EFFICACY OF CAS9-BASED KNOCK-IN STRATEGIES
#5AAV VECTOR VARIANTS FOR OCULAR GENE DELIVERY
#6METHODS FOR IMPROVED HOMOLOGOUS RECOMBINATION AND COMPOSITIONS THEREOF
#7METHODS AND COMPOSITIONS FOR THE TARGETED MODIFICATION OF A GENOME
#8PEPTIDE-BASED TRANSDUCTION OF NON-ANIONIC POLYNUCLEOTIDE ANALOGS FOR GENE EXPRESSION MODULATION
#9PEPTIDES HAVING SPECIFICITY FOR THE LUNGS
#10DIRECT REPLACEMENT GENOME EDITING
#11ADENOVIRUS COMPRISING A MODIFIED ADENOVIRUS HEXON PROTEIN
#12Adeno-Associated Virus Virions with Variant Capsid and Methods of Use Thereof
#13COMPOUND AND METHOD FOR TREATING MYOTONIC DYSTROPHY
#14Homogeneous engineered phage populations
#15PEPTIDES HAVING SPECIFICITY FOR THE LUNGS
#16COMPOSITIONS AND METHODS FOR IMPROVING THE EFFICACY OF CAS9-BASED KNOCK-IN STRATEGIES
#17Membrane-penetrating peptides to enhanced transfection and compositions and methods for using same
#18ENDOPLASMIC RETICULUM TARGETING SIGNAL
#19Methods and compositions for the targeted modification of a genome
#20Cell line which is knock out the bmp receptor genes and a method of producing target proteins using the same
#21Biologically active synthetic nanoparticle constructs and methods of use thereof
#22MODIFIED UBE3A GENE FOR A GENE THERAPY APPROACH FOR ANGELMAN SYNDROME
#23INTEGRATION OF MESA RECEPTORS AND PROMOTORS TO IMPLEMENT CUSTOMIZED CELLULAR FUNCTION
#24Compound and method for treating myotonic dystrophy
#25Adeno-associated virus virions with variant capsid
#26SELF-ITERATING EXOSOMAL VECTOR FOR EFFECTIVE BIOMOLECULAR TRANSFERS
#27METHODS FOR IMPROVED HOMOLOGOUS RECOMBINATION AND COMPOSITIONS THEREOF
#28Methods and compositions for the targeted modification of a mouse ES cell genome
#29POROUS NANOPARTICLE-SUPPORTED LIPID BILAYERS (PROTOCELLS) FOR TARGETED DELIVERY AND METHODS OF USING SAME
#30CHEMICALLY ACTIVATED NANOCAPSID FUNCTIONALIZED FOR CANCER TARGETING
#31Homogeneous engineered phage populations
#32BIOLOGICALLY ACTIVE SYNTHETIC NANOPARTICLE CONSTRUCTS AND METHODS OF USE THEREOF
#33Membrane bound reporter molecules and their use in cell sorting
#34POLYNUCLEOTIDES HAVING BIOREVERSIBLE GROUPS
#35Membrane-penetrating peptides to enhance transfection and compositions and methods for using same
#36Synthetic pathway for biological carbon dioxide sequestration
#37ANTI-TAU CONSTRUCTS
#38JC polyomavirus VLP (virus-like particle) with a targeting peptide
#39METHODS AND COMPOSITIONS FOR TREATING BRAIN DISEASES
#40Biologically active synthetic nanoparticle constructs and methods of use thereof
#41Methods and compositions for the targeted modification of a mouse embryonic stem cell genome
#42Adeno-associated virus virions with variant capsid and methods of use thereof
#43Adeno-associated virus virions with variant capsid and methods of use thereof
#44Adeno-associated virus virions with variant capsid and methods of use thereof
#45Peptides having specificity for the lungs
#46Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
#47SELF-ITERATING EXOSOMAL VECTOR FOR EFFECTIVE BIOMOLECULAR TRANSFERS
#48Polynucleotides having bioreversible groups
#49Dextran-peptide hybrid for efficient gene delivery
#50Adeno-associated virus virions with variant capsid and methods of use thereof
#51Membrane-penetrating peptides to enhance transfection and compositions and methods for using same
#52Method for engineering proteases and protein kinases
#53Compound and method for treating myotonic dystrophy
#54Filamentous bacteriophage as an angiogenesis modulator
#55Compound and method for treating myotonic dystrophy
#56Adeno-associated virus virions with variant capsid and methods of use thereof
#57Infectivity-enhanced conditionally-replicative adenovirus and uses thereof
#58Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
#59Encryption of adeno-associated viruses with enzymatically decoded peptide locks
#60Compositions and methods for retargeting virus constructs
#61Lipid membrane structure having intranuclear migrating property
#62Viral Vectors with Improved Properties
#63INFECTIVITY-ENHANCED CONDITIONALLY-REPLICATIVE ADENOVIRUS AND USES THEREOF
#64Modified AAV capsid polypeptides
#65Nonviral vectors for delivering polynucleotides to target tissue
#66Compound and method for treating myotonic dystrophy
#67Human and mouse targeting peptides identified by phage display
#68COMPOSITIONS AND METHODS OF USE OF TARGETING PEPTIDES FOR DIAGNOSIS AND THERAPY OF HUMAN CANCER
#69COMPOUND AND METHOD FOR TREATING MYOTONIC DYSTROPHY
#70Peptides that target dorsal root ganglion neurons
#71Methods and systems for high homologous recombination (“HR”) targeting efficiency
#72Infectivity-enhanced conditionally-replicative adenovirus and uses thereof
#73POLYPEPTIDE-NUCLEIC ACID CONJUGATES AND USES THEREOF
#74CHIMERIC FOOT AND MOUTH DISEASE VIRUSES
#75Simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome for systemic administration of a therapeutic or diagnostic agent
#76Reoviruses
#77AVV Vectors and Methods
#78Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
#79MODULAR ANTIGEN TRANSPORTER MOLECULES (MAT MOLECULES) FOR MODULATING IMMUNE REACTIONS, ASSOCIATED CONSTRUCTS, METHODS AND USES
#80COMPOUND AND METHOD FOR TREATING MYOTONIC DYSTROPHY
#81Nonviral vectors for delivering polynucleotides to target tissues
#82Engineered Baculoviruses and Their Use
#83Methods and compositions for treating brain diseases
#84Tissue specific peptide conjugates and methods
#85Agents And Methods For Early Diagnosis And Monitoring Of Alzheimer's Disease And Other Neurological Disorders
#86Cancer-targeted viral vectors
#87Methods and systems for high homologous recombination (“HR”) targeting efficiency
#88Protein isolation
#89Peptide compositions for targeting adipose tissue
#90Targeted artificial gene delivery
#91Dna-Carrier Conjugate
#92Immunologically enhanced recombinant vaccines
#93Random peptide library displayed on aav vectors
#94Viral vectors with improved properties
#95Recombinant modified adenovirus fiber protein
#96Enhanced delivery via serpin enzyme complex receptor
#97Modified adenoviral fiber with ablated to cellular receptors
#98Virus vectors and methods of making and administering the same
#99Virus vectors and methods of making and administering the same
#100Circular expression construct for gene therapeutic applications
#101Gene therapeutics
#102Targeted adenovirus vectors for delivery of heterologous genes
#103AAV vectors and methods
#104Cancer - targeted viral vectors
#105Modular antigen transporter molecules (MAT molecules) for modulating immune reactions, associated constructs, methods and uses
#106Vectors and methods for gene transfer
#107Pharmaceutical- or gene-carrier compositions with reduced hemagglutinating activity
#108Engineered baculoviruses and their use
#109Dipeptide apoptosis inhibitors and the use thereof
#110Modified adenovirus containing a fiber replacement protein
#111Protein isolation
#112Lipid-comprising drug delivery complexes and methods for their production
#113Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site